SEC Form 4 · accession 0001104659-17-075717
Jaguar Health, Inc. · JAGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lisa A Conte
Officer — CEO and President · Director
Period of report
Dec 21, 2017
Accepted (ET)
Dec 29, 2017 · 5:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001585608
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $0.12 | Dec 21, 2017 | A | 285,807 | A | — | Dec 21, 2027 | Common Stock | 285,807 | 285,807 | D |
Explanation of responses
- F1Granted pursuant to the Issuer's 2014 Equity Incentive Plan
- F2Vests in full on March 31, 2018 if reporting person is an employee as of such date.